FDA Approved: NUVIGIL — Supplemental Application (Cephalon, LLC)

View source ↗

Summary

FDA approved a supplemental application for NuVigil (armodafinil) submitted by Cephalon, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea-hypopnea Syndrome
• Shift Work Sleep Disorder

Drugs mentioned

• NUVIGIL (armodafinil)

Snippet

SUPPL AP for NUVIGIL (ARMODAFINIL)